French health officials received dozens of reports of syringe pricks at a public festival, sparking fear about HIV and ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

Aurobindo Pharma has been selected as one of the generic manufacturers under the expanded voluntary licensing agreement between the Medicines Patent Pool (MPP) and ViiV Healthcare.

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...

ViiV & MPP extend voluntary licensing long-acting injectable HIV treatment, Indian pharma to benefit: Our Bureau, Bengaluru Tuesday, July 15, 2025, 12:45 Hrs [IST] ViiV Healthcare ...

A study of more than 1 million people found no link between aluminum in vaccines and an increased risk of autoimmune disease, ...

As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...

Belgium has approved visas for Rawan Alkatari’s husband and three children, but they remain stuck in the Strip.

The impacts to liver health from a unique strain of chronic hepatitis B, which predominantly affects First Nations people, ...

Discover how the WHO's new guidelines on lenacapavir could revolutionise HIV prevention, offering a long-acting alternative ...

This landmark policy action aims to reshape the global HIV response by providing a highly effective, long-acting alternative ...

New Data from PURPOSE Trials Further Demonstrate that Lenacapavir (Yeztugo®) was Effective and Well Tolerated Across a Broad Range of Populations, Including ...